Position in AZN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,095,244
New position
Shares Held
5,776
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#653
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 92%
Shared 0%
None 8%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grove Bank & Trust holds $25,083,993 across 15 Drug Manufacturers - General names. AZN ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,571 | $9,080,885 | |
| 2 | ABBV |
AbbVie Inc.
|
15,353 | $3,863,428 | |
| 3 | JNJ |
Johnson & Johnson
|
15,184 | $3,856,280 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,556 | $1,998,945 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
22,434 | $1,292,646 | |
| 6 | AMGN |
Amgen Inc
|
3,253 | $1,177,976 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
5,776 | $1,095,244 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,271 | $792,278 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,095,244 | 5,776 | Shares | Defined | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||